On the public citation graph

Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation

0 signed · 275 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1995.03520390071036openalex-snapshot
Does This Patient Have Hypertension?
inferredcites →https://doi.org/10.1001/jama.273.15.1211openalex-snapshot
The rational clinical examination. Does this patient have hypertension? How to measure blood pressure
inferredcites →https://doi.org/10.1002/pd.2660openalex-snapshot
Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks
inferredcites →https://doi.org/10.1038/sj.jhh.1000889openalex-snapshot
Stability of blood pressure: is a sequential blood pressure reading protocol efficient for a large-scale community screening programme
inferredcites →https://doi.org/10.1038/sj.jhh.1002302openalex-snapshot
Blood pressure levels correlate with intra-individual variability using an automated device in early pregnancy
inferredcites →https://doi.org/10.1081/prg-100104165openalex-snapshot
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
inferredcites →https://doi.org/10.1093/clinchem/39.4.561openalex-snapshot
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
inferredcites →https://doi.org/10.1093/humrep/den224openalex-snapshot
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-A
inferredcites →https://doi.org/10.1097/00004872-200206000-00019openalex-snapshot
Inter-arm differences in blood pressure: when are they clinically significant?
inferredcites →https://doi.org/10.1097/00004872-200412000-00009openalex-snapshot
Patient characteristics and factors associated with inter-arm difference of blood pressure measurements in a general population in Ohasama, Japan
inferredcites →https://doi.org/10.1097/01.mbp.0000200481.64787.c0openalex-snapshot
Automated blood pressure measurement in routine clinical practice
inferredcites →https://doi.org/10.1097/aog.0b013e3181e9322aopenalex-snapshot
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
inferredcites →https://doi.org/10.1111/j.0954-6820.1988.tb05569.xopenalex-snapshot
Combining repeated blood pressure measurements to obtain prevalences of high blood pressure
inferredcites →https://doi.org/10.1111/j.1471-0528.1975.tb00710.xopenalex-snapshot
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
inferredcites →https://doi.org/10.1111/j.1471-0528.2005.00617.xopenalex-snapshot
An accurate automated blood pressure device for use in pregnancy and pre‐eclampsia: the Microlife 3BTO‐A
inferredcites →https://doi.org/10.1159/000324320openalex-snapshot
Turning the Pyramid of Prenatal Care
inferredcites →https://doi.org/10.1161/01.cir.0000154900.76284.f6openalex-snapshot
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4767635openalex-extracted
Implementation of First-Trimester Screening and Prevention of Preeclampsia: A Stepped Wedge Cluster-Randomised Trial in Asia
inferred← citeshttps://doi.org/10.1002/ajum.12101openalex-snapshot
Screening and prevention of pre‐term pre‐eclampsia – A prime time to act
inferred← citeshttps://doi.org/10.1002/ajum.12111openalex-snapshot
How to perform first trimester combined screening for pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/ijgo.12802openalex-snapshot
The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention
inferred← citeshttps://doi.org/10.1002/ijgo.14049openalex-snapshot
Routine first trimester combined screening for preterm preeclampsia in Australia: A multicenter clinical implementation cohort study
inferred← citeshttps://doi.org/10.1002/ijgo.15755openalex-snapshot
A prediction model for stillbirth based on first trimester pre‐eclampsia combined screening
inferred← citeshttps://doi.org/10.1002/ijgo.15786openalex-snapshot
Biomarkers in the prediction of complications in pregnancy after assisted reproductive technology
inferred← citeshttps://doi.org/10.1002/pd.4397openalex-snapshot
First‐trimester maternal factors and biomarker screening for preeclampsia
inferred← citeshttps://doi.org/10.1002/uog.12444openalex-snapshot
First-trimester uterine artery Doppler examination in pregnancies complicated by gestational diabetes mellitus with or without pre-eclampsia
inferred← citeshttps://doi.org/10.1002/uog.13257openalex-snapshot
Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.14777openalex-snapshot
Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks
inferred← citeshttps://doi.org/10.1002/uog.14783openalex-snapshot
Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history
inferred← citeshttps://doi.org/10.1002/uog.14847openalex-snapshot
Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks
inferred← citeshttps://doi.org/10.1002/uog.14855openalex-snapshot
Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks
inferred← citeshttps://doi.org/10.1002/uog.14863openalex-snapshot
Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks
inferred← citeshttps://doi.org/10.1002/uog.15663openalex-snapshot
Biophysical and biochemical markers at 35–37 weeks' gestation in the prediction of adverse perinatal outcome
inferred← citeshttps://doi.org/10.1002/uog.15807openalex-snapshot
Contingent screening for preterm pre-eclampsia
inferred← citeshttps://doi.org/10.1002/uog.15812openalex-snapshot
Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.15815openalex-snapshot
Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia
inferred← citeshttps://doi.org/10.1002/uog.17309openalex-snapshot
Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.17399openalex-snapshot
Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.17403openalex-snapshot
Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.17418openalex-snapshot
Proposed clinical management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.17419openalex-snapshot
Proposed clinical management of pregnancies after combined screening for pre‐eclampsia at 35–37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.17455openalex-snapshot
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
inferred← citeshttps://doi.org/10.1002/uog.17467openalex-snapshot
Protocol for the prospective validation study: ‘Screening programme for pre‐eclampsia’ ( SPREE )
inferred← citeshttps://doi.org/10.1002/uog.17517openalex-snapshot
Impaired placentation in women with chronic hypertension who develop pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.17531openalex-snapshot
Competing‐risks model in screening for pre‐eclampsia in twin pregnancy according to maternal factors and biomarkers at 11–13 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.17553openalex-snapshot
Association of chronic hypertension with birth of small‐for‐gestational‐age neonate
inferred← citeshttps://doi.org/10.1002/uog.18816openalex-snapshot
ASPRE trial: performance of screening for preterm pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.18899openalex-snapshot
Early screening and prevention of preterm pre‐eclampsia with aspirin: time for clinical implementation
inferred← citeshttps://doi.org/10.1002/uog.19019openalex-snapshot
ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
inferred← citeshttps://doi.org/10.1002/uog.19039openalex-snapshot
Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
inferred← citeshttps://doi.org/10.1002/uog.19077openalex-snapshot
Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE
inferred← citeshttps://doi.org/10.1002/uog.19099openalex-snapshot
Management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.19111openalex-snapshot
Screening for pre‐eclampsia at 35–37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.19112openalex-snapshot
Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.19116openalex-snapshot
Quality assessment of uterine artery Doppler measurement in first‐trimester combined screening for pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.20182openalex-snapshot
Local validation and calibration of pre‐eclampsia screening algorithms
inferred← citeshttps://doi.org/10.1002/uog.20231openalex-snapshot
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
inferred← citeshttps://doi.org/10.1002/uog.20852openalex-snapshot
Re: Prediction of pre‐eclampsia: review of reviews
inferred← citeshttps://doi.org/10.1002/uog.21867openalex-snapshot
Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening
inferred← citeshttps://doi.org/10.1002/uog.21905openalex-snapshot
First‐trimester pre‐eclampsia biomarker profiles in Asian population: multicenter cohort study
inferred← citeshttps://doi.org/10.1002/uog.22093openalex-snapshot
Screening for pre‐eclampsia at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A , placental growth factor or both
inferred← citeshttps://doi.org/10.1002/uog.22118openalex-snapshot
Maternal cardiac function in gestational diabetes mellitus at 35–36 weeks' gestation and 6 months postpartum
inferred← citeshttps://doi.org/10.1002/uog.22184openalex-snapshot
Ophthalmic artery Doppler in prediction of pre‐eclampsia at 35–37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23517openalex-snapshot
Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre‐eclampsia at 35–37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23521openalex-snapshot
Fetal cardiac function at 35–37 weeks' gestation in pregnancies that subsequently develop pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.23523openalex-snapshot
Competing‐risks model for prediction of small‐for‐gestational‐age neonate from biophysical and biochemical markers at 11–13 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23528openalex-snapshot
Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre‐eclampsia at 19–23 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23531openalex-snapshot
Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial
inferred← citeshttps://doi.org/10.1002/uog.23568openalex-snapshot
Maternal cardiac function at 19–23 weeks' gestation in prediction of pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.23601openalex-snapshot
Relationship between ophthalmic artery Doppler and maternal cardiovascular function
inferred← citeshttps://doi.org/10.1002/uog.23623openalex-snapshot
Stratification of pregnancy care based on risk of pre‐eclampsia derived from uterine artery Doppler at 19–24 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23640openalex-snapshot
Stratification of pregnancy care based on risk of pre‐eclampsia derived from biophysical and biochemical markers at 19–24 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23645openalex-snapshot
Prospective evaluation of first‐trimester screening strategy for preterm pre‐eclampsia and its clinical applicability in China
inferred← citeshttps://doi.org/10.1002/uog.23668openalex-snapshot
ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis
inferred← citeshttps://doi.org/10.1002/uog.23730openalex-snapshot
Second‐trimester contingent screening for small‐for‐gestational‐age neonate
inferred← citeshttps://doi.org/10.1002/uog.23741openalex-snapshot
Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis
inferred← citeshttps://doi.org/10.1002/uog.23742openalex-snapshot
Contingent screening in stratification of pregnancy care based on risk of pre‐eclampsia at 19–24 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.23760openalex-snapshot
Longitudinal assessment of spiral artery and intravillous arteriole blood flow and adverse pregnancy outcome
inferred← citeshttps://doi.org/10.1002/uog.24789openalex-snapshot
STATIN trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.24829openalex-snapshot
Estimated fetal weight at mid‐gestation in prediction of pre‐eclampsia in singleton pregnancy
inferred← citeshttps://doi.org/10.1002/uog.24850openalex-snapshot
First‐trimester screening for pre‐eclampsia: estimated vs measured mean arterial pressure
inferred← citeshttps://doi.org/10.1002/uog.24854openalex-snapshot
Ophthalmic artery Doppler at 35–37 weeks' gestation in pregnancies with small or growth‐restricted fetuses
inferred← citeshttps://doi.org/10.1002/uog.24874openalex-snapshot
Comparison of ophthalmic artery Doppler with PlGF and sFlt ‐1/ PlGF ratio at 35–37 weeks' gestation in prediction of imminent pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.24913openalex-snapshot
Ophthalmic artery Doppler at 19–23 weeks' gestation in pregnancies that deliver small‐for‐gestational‐age neonates
inferred← citeshttps://doi.org/10.1002/uog.24914openalex-snapshot
Ophthalmic artery Doppler at 11–13 weeks' gestation in prediction of pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.24915openalex-snapshot
Routine first‐trimester pre‐eclampsia screening and risk of preterm birth
inferred← citeshttps://doi.org/10.1002/uog.24918openalex-snapshot
Impact of replacing or adding pregnancy‐associated plasma protein‐A at 11–13 weeks on screening for preterm pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.24929openalex-snapshot
Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study
inferred← citeshttps://doi.org/10.1002/uog.24956openalex-snapshot
Quality assessment of first‐trimester screening for preterm pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.26036openalex-snapshot
Competing‐risks model for pre‐eclampsia and adverse pregnancy outcomes
inferred← citeshttps://doi.org/10.1002/uog.26057openalex-snapshot
Competing‐risks model for prediction of small‐for‐gestational‐age neonate at 36 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.26105openalex-snapshot
Machine‐learning‐based prediction of pre‐eclampsia using first‐trimester maternal characteristics and biomarkers
inferred← citeshttps://doi.org/10.1002/uog.26233openalex-snapshot
Performance of first‐trimester combined screening for preterm pre‐eclampsia: findings from cohort of 10 110 pregnancies in Spain
inferred← citeshttps://doi.org/10.1002/uog.26291openalex-snapshot
Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing‐risks model
inferred← citeshttps://doi.org/10.1002/uog.26303openalex-snapshot
Screening for pre‐eclampsia by maternal serum glycosylated fibronectin at 11−13 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.26306openalex-snapshot
Routine first‐trimester pre‐eclampsia screening and maternal left ventricular geometry
inferred← citeshttps://doi.org/10.1002/uog.27442openalex-snapshot
Three‐dimensional echocardiography and strain cardiac imaging in women with pre‐eclampsia with follow‐up to 6 months postpartum
inferred← citeshttps://doi.org/10.1002/uog.27464openalex-snapshot
Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre‐eclampsia: validation and update of previous model
inferred← citeshttps://doi.org/10.1002/uog.27478openalex-snapshot
Validation of machine‐learning model for first‐trimester prediction of pre‐eclampsia using cohort from PREVAL study
inferred← citeshttps://doi.org/10.1002/uog.27481openalex-snapshot
Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
inferred← citeshttps://doi.org/10.1002/uog.27510openalex-snapshot
Performance of machine‐learning approach for prediction of pre‐eclampsia in a middle‐income country
inferred← citeshttps://doi.org/10.1002/uog.27616openalex-snapshot
Maternal cardiovascular function in midgestation is related to placental angiogenesis
inferred← citeshttps://doi.org/10.1002/uog.27622openalex-snapshot
Comparison of different methods of first‐trimester screening for preterm pre‐eclampsia: cohort study
inferred← citeshttps://doi.org/10.1002/uog.27640openalex-snapshot
First‐trimester screening identifies maternal cardiac maladaptation in midgestation
inferred← citeshttps://doi.org/10.1002/uog.29177openalex-snapshot
Prediction of pre‐eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks
inferred← citeshttps://doi.org/10.1002/uog.29222openalex-snapshot
Assessment of risk for pre‐eclampsia at mid‐gestation to define subsequent care
inferred← citeshttps://doi.org/10.1002/uog.29255openalex-snapshot
Aspirin delays preterm birth in pregnancies at high risk for preterm pre‐eclampsia: evidence from randomized clinical trial in Asia
inferred← citeshttps://doi.org/10.1002/uog.70027openalex-snapshot
Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study
inferred← citeshttps://doi.org/10.1002/uog.70176openalex-snapshot
Implementation of PlGF ‐based first‐trimester screening and aspirin prophylaxis for preterm pre‐eclampsia: clinical and economic evaluation
inferred← citeshttps://doi.org/10.1002/uog.70215openalex-snapshot
Longitudinal maternal hemodynamics in high‐risk pregnancies with different subtypes of pre‐eclampsia
inferred← citeshttps://doi.org/10.1002/uog.70291openalex-snapshot
Hypertension at 5 months postpartum in women with gestational diabetes
inferred← citeshttps://doi.org/10.1007/978-3-031-64928-8_17openalex-snapshot
Cerebrovascular Disease in Preeclampsia
inferred← citeshttps://doi.org/10.1007/978-3-032-23479-7_13openalex-snapshot
Preeclampsia Screening and Prediction
inferred← citeshttps://doi.org/10.1007/s00404-019-05146-4openalex-snapshot
Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study
inferred← citeshttps://doi.org/10.1007/s00404-023-06967-0openalex-snapshot
Prediction of adverse pregnancy outcomes by first-trimester components of metabolic syndrome: a prospective longitudinal study
inferred← citeshttps://doi.org/10.1007/s00404-024-07905-4openalex-snapshot
Maternal cell-free DNA in early pregnancy for preeclampsia screening: a systematic review
inferred← citeshttps://doi.org/10.1007/s11906-023-01291-zopenalex-snapshot
Cell-Free Nucleic Acids for Early Prediction of Preeclampsia
inferred← citeshttps://doi.org/10.1007/s12011-022-03178-7openalex-snapshot
The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
inferred← citeshttps://doi.org/10.1007/s13224-026-02350-6openalex-snapshot
Assessment of Maternal Cardiac Adaptations in Women with Gestational Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/s40477-025-01039-2openalex-snapshot
First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes
inferred← citeshttps://doi.org/10.1007/s40556-017-0146-yopenalex-snapshot
Screening for Preeclampsia
inferred← citeshttps://doi.org/10.1007/s40615-025-02680-7openalex-snapshot
Optimising Pre-Eclampsia Screening in Black Women; a Secondary Analysis of Data from Non-Intervention Screening Studies
inferred← citeshttps://doi.org/10.1016/j.ajog.2015.08.034openalex-snapshot
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2015.11.016openalex-snapshot
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2016.02.016openalex-snapshot
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2017.07.038openalex-snapshot
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history
inferred← citeshttps://doi.org/10.1016/j.ajog.2017.08.110openalex-snapshot
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2018.02.014openalex-snapshot
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
inferred← citeshttps://doi.org/10.1016/j.ajog.2018.10.092openalex-snapshot
Two-stage screening for preterm preeclampsia at 11–13 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2018.11.1087openalex-snapshot
Predictive performance of the competing risk model in screening for preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2019.01.227openalex-snapshot
Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2019.01.235openalex-snapshot
Prediction of imminent preeclampsia at 35–37 weeks gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2019.02.034openalex-snapshot
Aspirin delays the development of preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2019.09.041openalex-snapshot
Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
inferred← citeshttps://doi.org/10.1016/j.ajog.2020.01.011openalex-snapshot
Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35–37 weeks of gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2020.04.019openalex-snapshot
Paired maternal and fetal cardiac functional measurements in women with gestational diabetes mellitus at 35–36 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2020.07.020openalex-snapshot
First trimester preeclampsia screening and prediction
inferred← citeshttps://doi.org/10.1016/j.ajog.2021.04.247openalex-snapshot
Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.ajog.2022.03.007openalex-snapshot
Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2023.09.095openalex-snapshot
Maternal vascular indices at 36 weeks’ gestation in the prediction of preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2024.04.032openalex-snapshot
Blood pressure cutoffs at 11-13 weeks of gestation and risk of preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2024.08.039openalex-snapshot
Evidence that systemic vascular resistance is increased before the development of gestational diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.ajog.2024.11.007openalex-snapshot
Effect of aspirin on biomarker profile in women at high risk for preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ajog.2025.01.018openalex-snapshot
At mid-gestation, markers of placental function rather than maternal cardiac function are stronger determinants of birthweight
inferred← citeshttps://doi.org/10.1016/j.ajogmf.2023.101110openalex-snapshot
Preterm preeclampsia screening using biomarkers: combining phenotypic classifiers into robust prediction models
inferred← citeshttps://doi.org/10.1016/j.bpobgyn.2023.102436openalex-snapshot
Prediction of preeclampsia in asymptomatic women
inferred← citeshttps://doi.org/10.1016/j.cct.2016.07.003openalex-snapshot
An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol
inferred← citeshttps://doi.org/10.1016/j.echo.2023.05.008openalex-snapshot
Fetal Cardiac Function at Midgestation and Subsequent Development of Preeclampsia
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2018.11.006openalex-snapshot
Risk assessment for preterm preeclampsia in first trimester: Comparison of three calculation algorithms
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2020.03.018openalex-snapshot
A comparison of first trimester blood pressures obtained at the time of first trimester pre-eclampsia screening and those obtained during prenatal care visits
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e19527openalex-snapshot
Evaluation of impacts of aspirin therapy versus placebo on preeclampsia: An observational study
inferred← citeshttps://doi.org/10.1016/j.jacc.2021.10.033openalex-snapshot
Maternal Cardiac Function at Midgestation and Development of Preeclampsia
inferred← citeshttps://doi.org/10.1016/j.jogc.2022.03.002openalex-snapshot
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management
inferred← citeshttps://doi.org/10.1016/j.jogc.2022.03.003openalex-snapshot
Directive clinique no 426 : Troubles hypertensifs de la grossesse : Diagnostic, prédiction, prévention et prise en charge
inferred← citeshttps://doi.org/10.1016/j.jogc.2025.103087openalex-snapshot
Preeclampsia Screening Taking Into Account Ethnicity and Socioeconomic Status—A Comparison of the Competing Risks Model and Risk Factor Scoring
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2025.101582openalex-snapshot
Effect of aspirin on small for gestational age neonates in pregnancies at high-risk for preeclampsia: a secondary analysis of a cluster randomised clinical trial
inferred← citeshttps://doi.org/10.1016/j.placenta.2025.05.019openalex-snapshot
Correlation between first trimester placental growth factor levels and skin microvascular reactivity assessed by laser speckle contrast imaging - a cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.preghy.2016.06.002openalex-snapshot
Bedside cardiovascular maternal interrogation in the first trimester to predict different phenotypes of hypertensive disorders in pregnancy
inferred← citeshttps://doi.org/10.1016/j.preghy.2017.08.002openalex-snapshot
Protocol for measurement of mean arterial pressure at 10–40 weeks’ gestation
inferred← citeshttps://doi.org/10.1016/j.preghy.2024.101114openalex-snapshot
Comparison of clinic and home blood pressure readings in higher risk pregnancies – Secondary analysis of the BUMP 1 trial
inferred← citeshttps://doi.org/10.1016/j.preghy.2025.101211openalex-snapshot
Prevent-PE (pre-eclampsia prevention by timed birth at term): Protocol for a randomised trial
inferred← citeshttps://doi.org/10.1016/j.preghy.2025.101236openalex-snapshot
First trimester preeclampsia screening and risk of placental lesions
inferred← citeshttps://doi.org/10.1016/j.rbmo.2022.10.007openalex-snapshot
High concentration of first-measured HCG after embryo transfer is associated with subsequent development of pre-eclampsia
inferred← citeshttps://doi.org/10.1016/j.repbio.2025.101047openalex-snapshot
Physical activity pattern and Pre-eclampsia risk biomarkers: an observational study
inferred← citeshttps://doi.org/10.1016/j.tjog.2023.09.023openalex-snapshot
Ultrasonographic placental parameters at 11–13+6 weeks’ gestation in the prediction of complications in pregnancy after assisted reproductive technology
inferred← citeshttps://doi.org/10.1016/j.xagr.2022.100052openalex-snapshot
Predictive ability of serum advanced glycation end products at 11 to 13 weeks of gestation for early-onset preeclampsia
inferred← citeshttps://doi.org/10.1016/s0140-6736(25)01207-3openalex-snapshot
Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial
inferred← citeshttps://doi.org/10.1038/hr.2017.6openalex-snapshot
Provisional criteria for the diagnosis of hypertension in pregnancy using home blood pressure measurements
inferred← citeshttps://doi.org/10.1038/s41372-025-02316-yopenalex-snapshot
Comparison of first trimester preeclampsia combined screening performances with various approaches in the Indonesian population
inferred← citeshttps://doi.org/10.1038/s41440-020-00571-4openalex-snapshot
Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11–13 weeks of gestation in a Japanese population
inferred← citeshttps://doi.org/10.1055/s-0038-1677476openalex-snapshot
Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT
inferred← citeshttps://doi.org/10.1055/s-0040-1712124openalex-snapshot
Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
inferred← citeshttps://doi.org/10.1055/s-0041-1741087openalex-snapshot
Reducing Perinatal Mortality in India: Two-Years Results of the IRIA Fetal Radiology Samrakshan Program
inferred← citeshttps://doi.org/10.1055/s-0042-1759483openalex-snapshot
Impact of the Community-Integrated Model of Samrakshan on Perinatal Mortality and Morbidity in Guna District of Central India
inferred← citeshttps://doi.org/10.1055/s-0042-1759856openalex-snapshot
Effectiveness of the First Trimester Samrakshan Protocol for the Identification of Pregnant Women at High Risk for Preterm Pre-eclampsia
inferred← citeshttps://doi.org/10.1055/s-0043-1761250openalex-snapshot
A Comparison of Changes in the Mean Arterial Blood Pressure and Mean Uterine Artery Pulsatility Index from 11–14 to 19–24 + 6 Gestation Weeks in Low-Risk and High-Risk Asian Indian Pregnant Women
inferred← citeshttps://doi.org/10.1056/nejmoa1704559openalex-snapshot
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
inferred← citeshttps://doi.org/10.1080/00365513.2022.2155991openalex-snapshot
First trimester serum apolipoproteins in the prediction of late-onset preeclampsia
inferred← citeshttps://doi.org/10.1080/10641955.2019.1682009openalex-snapshot
FIRST TRIMESTER SCREENING FOR PREECLAMPSIA – A SYSTEMATIC REVIEW
inferred← citeshttps://doi.org/10.1080/10641955.2020.1750627openalex-snapshot
Concordance-analysis and evaluation of different diagnostic algorithms used in first trimester screening for late-onset preeclampsia
inferred← citeshttps://doi.org/10.1080/14767058.2017.1357168openalex-snapshot
Serum-free placental growth factor isoform 1 at 11–13-week gestation: effects of maternal factors, mean arterial pressure, placental volume, and uterine artery pulsatility index
inferred← citeshttps://doi.org/10.1080/14767058.2020.1767059openalex-snapshot
Pre-eclampsia screening in the first trimester – preemptive action to prevent the peril
inferred← citeshttps://doi.org/10.1080/14767058.2021.1879043openalex-snapshot
Fetal fraction of cell free DNA in screening for hypertensive disorders at 11–13 weeks
inferred← citeshttps://doi.org/10.1080/14767058.2026.2721948openalex-snapshot
First-trimester uterine artery doppler in pregnancies with reactive hypoglycaemia or low 2-hour oral glucose tolerance test value: a retrospective study
inferred← citeshttps://doi.org/10.1089/tmr.2020.0021openalex-snapshot
Examining the Feasibility of Smart Blood Pressure Home Monitoring: Advancing Remote Prenatal Care in Rural Appalachia
inferred← citeshttps://doi.org/10.1097/01.ogx.0000528015.09400.25openalex-snapshot
Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
inferred← citeshttps://doi.org/10.1097/fm9.0000000000000005openalex-snapshot
Screening and Prevention of Preeclampsia
inferred← citeshttps://doi.org/10.1097/fm9.0000000000000098openalex-snapshot
Risk Factors for Preeclampsia: Results from a Cohort of Over 5000 Pregnancies in Spain
inferred← citeshttps://doi.org/10.1101/2023.04.26.23289181openalex-snapshot
Prediction of Future Chronic Hypertension from Maternal Characteristics in Early Pregnancy
inferred← citeshttps://doi.org/10.1111/1471-0528.14970openalex-snapshot
First trimester screening for pre‐eclampsia in Chinese pregnancies: case–control study
inferred← citeshttps://doi.org/10.1111/1471-0528.15664openalex-snapshot
Evaluation of a simple risk score to predict preterm pre‐eclampsia using maternal characteristics: a prospective cohort study
inferred← citeshttps://doi.org/10.1111/1471-0528.16361openalex-snapshot
Implementation of routine first trimester combined screening for pre‐eclampsia: a clinical effectiveness study
inferred← citeshttps://doi.org/10.1111/1471-0528.16815openalex-snapshot
Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model
inferred← citeshttps://doi.org/10.1111/1471-0528.17096openalex-snapshot
Serum PlGF compared with PAPP‐A in first trimester screening for preterm pre‐eclampsia: Adjusting for the effect of aspirin treatment
inferred← citeshttps://doi.org/10.1111/1471-0528.17560openalex-snapshot
Adverse pregnancy outcomes in women at increased risk of preterm pre‐eclampsia on first‐trimester combined screening
inferred← citeshttps://doi.org/10.1111/1471-0528.17673openalex-snapshot
First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth
inferred← citeshttps://doi.org/10.1111/1471-0528.18091openalex-snapshot
Maternal Calcium Intake at 36 Weeks' Gestation and Pre‐Eclampsia Risk—A Cohort Study
inferred← citeshttps://doi.org/10.1111/1471-0528.70275openalex-snapshot
Pre‐Eclampsia and Maternal Cardiovascular Function: Insights Into Pathophysiology and Care (Scientific Impact Paper No. 79)
inferred← citeshttps://doi.org/10.1111/ajo.12126openalex-snapshot
Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy
inferred← citeshttps://doi.org/10.1111/ajo.12689openalex-snapshot
Accuracy of second trimester prediction of preterm preeclampsia by three different screening algorithms
inferred← citeshttps://doi.org/10.1111/ajo.12951openalex-snapshot
Clinical evaluation of a first trimester pregnancy algorithm predicting the risk of small for gestational age neonates
inferred← citeshttps://doi.org/10.1111/ajo.13113openalex-snapshot
Prediction of preterm pre‐eclampsia at midpregnancy using a multivariable screening algorithm
inferred← citeshttps://doi.org/10.1111/ajo.70170openalex-snapshot
Improving Clinical Outcomes Related to Preeclampsia: Real‐World Impacts of Implementation of a Redesigned Approach to Antenatal Care—The Initial Maternity Assessment and Planning ( IMAP ) Service
inferred← citeshttps://doi.org/10.1111/aogs.13890openalex-snapshot
Screening for preeclampsia in low‐risk twin pregnancies at early gestation
inferred← citeshttps://doi.org/10.1111/aogs.14618openalex-snapshot
Biomarkers at 6 weeks' gestation in the prediction of early miscarriage in pregnancy following assisted reproductive technology
inferred← citeshttps://doi.org/10.1111/aogs.70002openalex-snapshot
External validation of the Fetal Medicine Foundation model for preterm pre‐eclampsia prediction at 11–14 weeks in an Australian population
inferred← citeshttps://doi.org/10.1111/aogs.70263openalex-snapshot
Prospective evaluation of the Simple Fetal Medicine Foundation's first‐trimester prediction model for preeclampsia in twin pregnancies
inferred← citeshttps://doi.org/10.1111/aogs.70319openalex-snapshot
Assessing quality standards of biomarker measurement in first‐trimester combined screening for preeclampsia in the Chinese population: A multicenter study
inferred← citeshttps://doi.org/10.1111/jog.13599openalex-snapshot
Prediction and prevention of pre‐eclampsia in Asian subpopulation
inferred← citeshttps://doi.org/10.1111/jog.14524openalex-snapshot
Current update of first trimester preeclampsia screening in Asia
inferred← citeshttps://doi.org/10.1111/jog.15908openalex-snapshot
First‐trimester preterm preeclampsia prediction model for prevention with low‐dose aspirin
inferred← citeshttps://doi.org/10.1136/bmjopen-2016-011801openalex-snapshot
Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)
inferred← citeshttps://doi.org/10.1136/bmjopen-2018-022056openalex-snapshot
T rial of feasibility and acceptability of routine low-dose aspirin versus E arly S creening T est indicated aspirin for pre-eclampsia prevention ( TEST study): a multicentre randomised controlled trial
inferred← citeshttps://doi.org/10.1136/bmjopen-2019-033851openalex-snapshot
Study for Improving Maternal Pregnancy And Child ouTcomes (IMPACT): a study protocol for a Swedish prospective multicentre cohort study
inferred← citeshttps://doi.org/10.1136/bmjopen-2020-046161openalex-snapshot
Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-074493openalex-snapshot
Aspirin versus metformin in pregnancies at high risk of preterm pre-eclampsia in China (AVERT): protocol for a multicentre, double-blind, 3-arm randomised controlled trial
inferred← citeshttps://doi.org/10.1155/2014/297397openalex-snapshot
Early Prediction of Preeclampsia
showing the first 200 of 258 · page through all 258
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.